...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Porcine CTLA4-Ig Lacks a MYPPPY Motif, Binds Inefficiently to Human B7 and Specifically Suppresses Human CD4~+ T Cell Responses Costimulated by Pig But Not Human B7
【24h】

Porcine CTLA4-Ig Lacks a MYPPPY Motif, Binds Inefficiently to Human B7 and Specifically Suppresses Human CD4~+ T Cell Responses Costimulated by Pig But Not Human B7

机译:猪CTLA4-Ig缺乏MYPPPY母体,与人B7的结合效率低下,并特异性抑制猪共刺激的人CD4〜+ T细胞反应,但不抑制人B7

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The CTLA4 receptor (CD152) on activated T lymphocytes binds B7 molecules (CD80 and CD86) on APC and delivers a singal that inhibits T cell proliferation. Several regions involved in binding to B7 are knwon, but the relative importance of these is not clear. We have cloned porcine CTLA4 (pCTLA4). Although highly homologous to human CTLA4 (hCTLA4), the predicted protein sequence contains a leucine for methionine substitution at position 97 in the MYPPPY sequence. A fusion protein constructed from the extracellular regions of pCTLA4 and the constant regions of human IgG1 (pCTLA4-Ig) bound porcine CD86 with equivalent affinity to that of hCTLA4-Ig. Howver, pCTLA4-Ig bound poorly to human CD80 and CD86 expressed on transfectants and EBV-transformed human B cells. In functional assays with MHC class II-expressing porcine endothelial cells and human B cells, pCTLA4-Ig blocked human CD4~+ T cell responses to pig but not human cells, whereas control hCTLA4-Ig inhibited responses to both. Comparison between mouse, human, and porcine CTLA4-Ig suggests that the binding of pCTLA4-Ig to porcine CD86 molecules is due to the L for M substitution at position 97. Our results indicate that pCTLA4-Ig may be a useful reagent to define the precise nature of the interaction between B7 and CTLA4. By failing to inhibit the delivery of costimulatory signals provided by human B7, it may also prove to be a relatively inhibitor of the direct human T cell response to immunogenic pig tissue.
机译:活化的T淋巴细胞上的CTLA4受体(CD152)与APC上的B7分子(CD80和CD86)结合,并提供抑制T细胞增殖的信号。参与结合B7的几个区域是已知的,但这些的相对重要性尚不清楚。我们已经克隆了猪CTLA4(pCTLA4)。尽管与人CTLA4(hCTLA4)高度同源,但预测的蛋白质序列在MYPPPY序列的97位含有一个用于蛋氨酸取代的亮氨酸。由pCTLA4的细胞外区域和人IgG1恒定区(pCTLA4-Ig)构建的融合蛋白与猪CD86结合,具有与hCTLA4-Ig相同的亲和力。然而,pCTLA4-Ig与在转染子和EBV转化的人B细胞上表达的人CD80和CD86结合不良。在表达MHC II类的猪内皮细胞和人B细胞的功能测定中,pCTLA4-Ig阻断了人CD4 ++ T细胞对猪的反应,但没有阻断人细胞,而对照hCTLA4-Ig则抑制了对二者的反应。小鼠,人类和猪CTLA4-Ig之间的比较表明,pCTLA4-Ig与猪CD86分子的结合归因于L在97位的M取代。我们的结果表明,pCTLA4-Ig可能是定义CCTLA4-Ig的有用试剂。 B7与CTLA4之间相互作用的精确性质。通过未能抑制人B7提供的共刺激信号的传递,它也可能被证明是相对直接抑制人T细胞对免疫原性猪组织的反应的抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号